pubmed.ncbi.nlm.nih.gov

Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer - PubMed

Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer

Thomas Schweiger et al. Clin Exp Metastasis. 2016 Oct.

Abstract

The presence of tumor-infiltrating lymphocytes (TILs) and tertiary lymphoid structures (TLSs) reflects an active inflammatory tumor microenvironment. High density of TILs as well as presence of TLS is associated with improved survival in various solid cancer types. We aimed to describe the density and distribution of TILs and TLS in pulmonary metastases (PMs) from primary colorectal cancer (CRC) and its correlation with clinicopathological variables. Fifty-seven CRC pulmonary metastasectomy specimen (PM) and 31 matched primary CRC specimen were included. Cluster of differentiation (CD)3+, CD8+, CD45RO+ and FoxP3+ TILs were evaluated by immunohistochemistry and density was scored semiquantitatively. TLS were evaluated based on morphological criteria. Survival time was defined from pulmonary metastasectomy to death or last follow up. A marked infiltration with CD3+, CD8+, CD45RO+ and FoxP3+ TILs was evident in CRC PM and matched primary CRC. Further assessment of the immune infiltrate in PM showed that a high density of FOXP3+ TILs at the invasive margin [HR 2.40 (1.11-6.96); P = 0.031] and low density of CD8+ cells in TLS [HR 0.30 (0.14-0.79); P = 0.016] were associated with a worse prognosis in univariate analysis. Moreover, a low CD8/FoxP3-ratio of TILs at the invasive margin (P = 0.042) and in TLS (P = 0.027) conferred an impaired prognosis after pulmonary metastasectomy. Our findings suggest that CRC PM harbor an immune active microenvironment. The balance of CD8+ and FoxP3+ T-cells at the tumor border and in TLS provides prognostic information in patients with CRC PM.

Keywords: Colorectal cancer; Pulmonary metastasis; TILs; Tertiary lymphoid structures; Tumor-infiltrating lymphocytes.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1

Representative images of high densities of a CD3+, b CD8+, c CD45RO+ and d FoxP3+ TILs (DAB; brown) in pulmonary metastases. e CD3+ tertiary lymphoid structure at the invasive margin between tumor cells and lung parenchyma (magnification ×200/400). (Color figure online)

Fig. 2
Fig. 2

Kaplan–Meier estimates regarding recurrence-free survival and overall survival of pulmonary metastases dependent on the density of CD8+ and FoxP3+ TILs. Additionally the outcome for the CD8/FoxP3-ratio was calculated

Fig. 3
Fig. 3

Kaplan–Meier estimates regarding recurrence-free survival and overall survival of pulmonary metastases dependent on the density of CD8+ and FoxP3+ cells in TLS. Additionally the outcome for the CD8/FoxP3-ratio was calculated

Similar articles

Cited by

References

    1. Mitry E, et al. Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study. Gut. 2010;59(10):1383–1388. doi: 10.1136/gut.2010.211557. - DOI - PubMed
    1. Erstad DJ, Tumusiime G, Cusack JC., Jr Prognostic and predictive biomarkers in colorectal cancer: implications for the clinical surgeon. Ann Surg Oncol. 2015;22(11):3433–3450. doi: 10.1245/s10434-015-4706-x. - DOI - PubMed
    1. Renaud S, Falcoz PE. How can we identify new biomarkers for patients with for lung metastasectomy in colorectal cancer. Future Oncol. 2015;11(15):2109–2111. doi: 10.2217/fon.15.124. - DOI - PubMed
    1. Owusu BY, et al. Prognostic and predictive significance of stromal fibroblasts and macrophages in colon cancer. Biomark Cancer. 2015;7(Suppl 1):29–37. - PMC - PubMed
    1. Schweiger T, et al. Prognostic factors in pulmonary metastasectomy: spotlight on molecular and radiological markers. Eur J Cardiothorac Surg. 2014;45(3):408–416. doi: 10.1093/ejcts/ezt288. - DOI - PubMed

Publication types

MeSH terms